Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 4/2016

01.04.2016 | Original Article – Clinical Oncology

Which is the most suitable lymph node predictor for overall survival after primary surgery of head and neck cancer: pN, the number or the ratio of positive lymph nodes, or log odds?

verfasst von: Mehmet Metin Yildiz, Iver Petersen, Ekkehard Eigendorff, Peter Schlattmann, Orlando Guntinas-Lichius

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the best lymph node (LN) metastasis predictor for overall survival (OS) in head neck cancer (HNC): pN classification, number of positive lymph nodes (PNOD), lymph node ratio (LNR), or log odds of positive lymph nodes (LODDS).

Methods

In total, 225 surgically treated HNC patients were evaluated for the different LN classifications and OS.

Results

Five-year OS was 71.8 %. Mean number of yielded LN and PNOD was 25.3 ± 16.7 and 2.7 ± 5.9, respectively. 64.8 % had a LNR > 0.10 and 64.4 % a LODDS > 10. In univariable analysis, multimodal therapy (p = 0.039), advanced pT (p < 0.0001), advanced UICC stage (p = 0.029), LNR > 0.10 (p = 0.049), and LODDS > −1.0 (p = 0.021) were associated with lower OS. In multivariable analysis, advanced pT [hazard ratio (HR) 2.194; 95 % confidence interval (CI) 1.294–3.722; p = 0.004] and LODDS > −1.0 (HR 1.634; 95 % CI 1.002–2.665; p = 0.059) remained independent predictors for lower OS.

Conclusions

It seems useful to analyze the prognostic significance of LODDS in other samples of HNC.
Literatur
Zurück zum Zitat Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695–1709CrossRefPubMed Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695–1709CrossRefPubMed
Zurück zum Zitat Bernier J et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27:843–850CrossRefPubMed Bernier J et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27:843–850CrossRefPubMed
Zurück zum Zitat Chan AT, Grégoire V, Lefebvre JL, Licitra L, Hui EP, Leung SF, Felip E, EHNS–ESMO–ESTRO Guidelines Working Group (2012) Nasopharyngeal cancer: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii83–vii85CrossRefPubMed Chan AT, Grégoire V, Lefebvre JL, Licitra L, Hui EP, Leung SF, Felip E, EHNS–ESMO–ESTRO Guidelines Working Group (2012) Nasopharyngeal cancer: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii83–vii85CrossRefPubMed
Zurück zum Zitat Chen YL et al (2015) Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center. J Cancer Res Clin Oncol 141:333–343CrossRefPubMed Chen YL et al (2015) Prognostic influences of lymph node ratio in major cancers of Taiwan: a longitudinal study from a single cancer center. J Cancer Res Clin Oncol 141:333–343CrossRefPubMed
Zurück zum Zitat Ebrahimi A, Clark JR, Zhang WJ, Elliott MS, Gao K, Milross CG, Shannon KF (2011a) Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma. Head Neck 33:1245–1251CrossRefPubMed Ebrahimi A, Clark JR, Zhang WJ, Elliott MS, Gao K, Milross CG, Shannon KF (2011a) Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma. Head Neck 33:1245–1251CrossRefPubMed
Zurück zum Zitat Ebrahimi A, Zhang WJ, Gao K, Clark JR (2011b) Nodal yield and survival in oral squamous cancer: defining the standard of care. Cancer 117:2917–2925CrossRefPubMed Ebrahimi A, Zhang WJ, Gao K, Clark JR (2011b) Nodal yield and survival in oral squamous cancer: defining the standard of care. Cancer 117:2917–2925CrossRefPubMed
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual. Springer, New York Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual. Springer, New York
Zurück zum Zitat Ghadjar P et al (2010) Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 76:1127–1132CrossRefPubMed Ghadjar P et al (2010) Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 76:1127–1132CrossRefPubMed
Zurück zum Zitat Gil Z, Carlson DL, Boyle JO, Kraus DH, Shah JP, Shaha AR, Singh B, Wong RJ, Patel SG (2009) Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer 115:5700–5710CrossRefPubMed Gil Z, Carlson DL, Boyle JO, Kraus DH, Shah JP, Shaha AR, Singh B, Wong RJ, Patel SG (2009) Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer 115:5700–5710CrossRefPubMed
Zurück zum Zitat Grégoire V, Lefebvre JL, Licitra L, Felip E, EHNS–ESMO–ESTRO Guidelines Working Group (2010) Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v184–v186CrossRefPubMed Grégoire V, Lefebvre JL, Licitra L, Felip E, EHNS–ESMO–ESTRO Guidelines Working Group (2010) Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v184–v186CrossRefPubMed
Zurück zum Zitat Harari PM et al (2014) Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234. J Clin Oncol 32:2486–2495CrossRefPubMedPubMedCentral Harari PM et al (2014) Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234. J Clin Oncol 32:2486–2495CrossRefPubMedPubMedCentral
Zurück zum Zitat Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387CrossRefPubMed Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387CrossRefPubMed
Zurück zum Zitat Hua YH, Hu QY, Piao YF, Tang Q, Fu ZF (2015) Effect of number and ratio of positive lymph nodes in hypopharyngeal cancer. Head Neck 37:111–116CrossRefPubMed Hua YH, Hu QY, Piao YF, Tang Q, Fu ZF (2015) Effect of number and ratio of positive lymph nodes in hypopharyngeal cancer. Head Neck 37:111–116CrossRefPubMed
Zurück zum Zitat Kunzel J, Mantsopoulos K, Psychogios G, Agaimy A, Grundtner P, Koch M, Iro H (2015) Lymph node ratio is of limited value for the decision-making process in the treatment of patients with laryngeal cancer. Eur Arch Otorhinolaryngol 272:453–461. doi:10.1007/s00405-014-2997-3 CrossRefPubMed Kunzel J, Mantsopoulos K, Psychogios G, Agaimy A, Grundtner P, Koch M, Iro H (2015) Lymph node ratio is of limited value for the decision-making process in the treatment of patients with laryngeal cancer. Eur Arch Otorhinolaryngol 272:453–461. doi:10.​1007/​s00405-014-2997-3 CrossRefPubMed
Zurück zum Zitat Le Tourneau C, Velten M, Jung GM, Bronner G, Flesch H, Borel C (2005) Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases. Head Neck 27:801–808CrossRefPubMed Le Tourneau C, Velten M, Jung GM, Bronner G, Flesch H, Borel C (2005) Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases. Head Neck 27:801–808CrossRefPubMed
Zurück zum Zitat Lewis JS Jr, Carpenter DH, Thorstad WL, Zhang Q, Haughey BH (2011) Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma. Mod Pathol 24:1413–1420CrossRefPubMedPubMedCentral Lewis JS Jr, Carpenter DH, Thorstad WL, Zhang Q, Haughey BH (2011) Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma. Mod Pathol 24:1413–1420CrossRefPubMedPubMedCentral
Zurück zum Zitat Marres CC, de Ridder M, Hegger I, van Velthuysen ML, Hauptmann M, Navran A, Balm AJ (2014) The influence of nodal yield in neck dissections on lymph node ratio in head and neck cancer. Oral Oncol 50:59–64CrossRefPubMed Marres CC, de Ridder M, Hegger I, van Velthuysen ML, Hauptmann M, Navran A, Balm AJ (2014) The influence of nodal yield in neck dissections on lymph node ratio in head and neck cancer. Oral Oncol 50:59–64CrossRefPubMed
Zurück zum Zitat Patel SG et al (2013) Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research. Br J Cancer 109:2087–2095CrossRefPubMedPubMedCentral Patel SG et al (2013) Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research. Br J Cancer 109:2087–2095CrossRefPubMedPubMedCentral
Zurück zum Zitat Prabhu RS et al (2015) Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. Head Neck 37:777–782CrossRefPubMed Prabhu RS et al (2015) Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. Head Neck 37:777–782CrossRefPubMed
Zurück zum Zitat Preuss SF, Klussmann JP, Wittekindt C, Damm M, Semrau R, Drebber U, Guntinas-Lichius O (2007) Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinoma. Eur J Surg Oncol 33:358–363CrossRefPubMed Preuss SF, Klussmann JP, Wittekindt C, Damm M, Semrau R, Drebber U, Guntinas-Lichius O (2007) Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinoma. Eur J Surg Oncol 33:358–363CrossRefPubMed
Zurück zum Zitat RC Team (2104) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna RC Team (2104) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
Zurück zum Zitat Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25:127–141CrossRefPubMed Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25:127–141CrossRefPubMed
Zurück zum Zitat Shrime MG et al (2009) Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity. Head Neck 31:1482–1488CrossRefPubMed Shrime MG et al (2009) Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity. Head Neck 31:1482–1488CrossRefPubMed
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C (2010) TNM classification of malignant tumours. Blackwell, Oxford Sobin LH, Gospodarowicz MK, Wittekind C (2010) TNM classification of malignant tumours. Blackwell, Oxford
Zurück zum Zitat Stennert E, Kisner D, Jungehuelsing M, Guntinas-Lichius O, Schröder U, Eckel HE, Klussmann JP (2003) High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg 129:720–723CrossRefPubMed Stennert E, Kisner D, Jungehuelsing M, Guntinas-Lichius O, Schröder U, Eckel HE, Klussmann JP (2003) High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg 129:720–723CrossRefPubMed
Zurück zum Zitat Sun Z et al (2010) Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer 116:2571–2580CrossRefPubMed Sun Z et al (2010) Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer 116:2571–2580CrossRefPubMed
Zurück zum Zitat Vaidya AM, Petruzzelli GJ, Clark J, Emami B (2001) Patterns of spread in recurrent head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 125:393–396CrossRefPubMed Vaidya AM, Petruzzelli GJ, Clark J, Emami B (2001) Patterns of spread in recurrent head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 125:393–396CrossRefPubMed
Zurück zum Zitat Vander Poorten V, Bradly PJ, Takes RP, Rinaldo A, Woolgar JA, Ferlito A (2012) Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology. Head Neck 34:429–440CrossRefPubMed Vander Poorten V, Bradly PJ, Takes RP, Rinaldo A, Woolgar JA, Ferlito A (2012) Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology. Head Neck 34:429–440CrossRefPubMed
Zurück zum Zitat Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008) The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg 12:1790–1796CrossRefPubMed Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008) The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg 12:1790–1796CrossRefPubMed
Zurück zum Zitat Wittekind C, Compton C, Brierley J, Sobin LH (2012) TNM supplement: a commentary on uniform use. Wiley-Blackwell, Oxford Wittekind C, Compton C, Brierley J, Sobin LH (2012) TNM supplement: a commentary on uniform use. Wiley-Blackwell, Oxford
Metadaten
Titel
Which is the most suitable lymph node predictor for overall survival after primary surgery of head and neck cancer: pN, the number or the ratio of positive lymph nodes, or log odds?
verfasst von
Mehmet Metin Yildiz
Iver Petersen
Ekkehard Eigendorff
Peter Schlattmann
Orlando Guntinas-Lichius
Publikationsdatum
01.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 4/2016
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-015-2104-1

Weitere Artikel der Ausgabe 4/2016

Journal of Cancer Research and Clinical Oncology 4/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.